Guided Therapeutics (GTHP) Interest Coverage Ratio Growth (1y) (2011 - 2025)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Cover Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -40.19%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 3.52%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -12.04%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 8.92%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -54.61%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -6.18%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 66.99%
10 Guided Therapeutics - - 458,000.00 3.17%

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 3.17%
Sep 30, 2025 27.62%
Jun 30, 2025 44.35%
Mar 31, 2025 49.79%
Dec 31, 2024 40.84%
Sep 30, 2024 40.80%
Jun 30, 2024 59.96%
Mar 31, 2024 56.08%
Dec 31, 2023 50.26%
Sep 30, 2023 -11.12%
Jun 30, 2023 -678.77%
Mar 31, 2023 -191.21%
Dec 31, 2022 -211.33%
Sep 30, 2022 -863.18%
Jun 30, 2022 -57.26%
Mar 31, 2022 24.85%
Dec 31, 2021 -120.52%
Sep 30, 2021 -69.87%
Jun 30, 2021 -48.65%
Mar 31, 2021 -592.22%
Dec 31, 2020 -380.60%
Sep 30, 2020 3.47%
Jun 30, 2020 3.28%
Mar 31, 2020 -21.72%
Dec 31, 2019 11.51%
Sep 30, 2019 48.93%
Jun 30, 2019 25.33%
Mar 31, 2019 55.05%
Dec 31, 2018 81.47%
Sep 30, 2018 80.40%
Jun 30, 2018 -1.15%
Mar 31, 2018 33.14%
Dec 31, 2017 33.03%
Sep 30, 2017 -66.30%
Jun 30, 2017 -121.53%
Mar 31, 2017 67.77%
Dec 31, 2016 81.36%
Sep 30, 2016 33.96%
Jun 30, 2016 85.06%
Mar 31, 2016 -136.47%
Dec 31, 2015 -398.27%
Sep 30, 2015 30.11%
Jun 30, 2015 88.51%
Mar 31, 2015 96.07%
Dec 31, 2014 97.02%
Sep 30, 2014 95.63%
Jun 30, 2014 77.71%
Mar 31, 2014 38.40%
Dec 31, 2013 -131.36%
Sep 30, 2013 -145.92%
Jun 30, 2013 -220.16%
Mar 31, 2013 -113.35%
Dec 31, 2012 63.56%
Sep 30, 2012 51.94%
Jun 30, 2012 -124.24%
Mar 31, 2012 -82.10%
Jun 30, 2011 -242.08%